Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 USD | -3.73% | -5.84% | -14.57% |
May. 07 | Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M | MT |
May. 07 | Opko Health, Inc. Provides Earnings Guidance for the Second Quarter of 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.57% | 899M | C | ||
-22.13% | 7.9B | B+ | ||
+76.16% | 4.53B | C+ | ||
+8.56% | 2.78B | B- | ||
-50.41% | 1.99B | B- | ||
-19.59% | 1.66B | C- | ||
-20.07% | 1.49B | A- | ||
+19.31% | 1.23B | B+ | ||
-45.78% | 1.1B | C+ | ||
+20.02% | 996M | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OPK Stock
- Ratings OPKO Health, Inc.